Physician profile
Michael Degen
NPI 1174962757
$4,677.36
in general payments reported to CMS, 2019-2025
15 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,492 · 2020: $149 · 2021: $227 · 2022: $1,290 · 2023: $268 · 2024: $857 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,520.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,038.72 | 2019-2025 | Stone Cone, Lithovue, Axonics |
| Procept Biorobotics Corporation | $829.35 | 2022 | |
| Intuitive Surgical, INC. | $732.18 | 2019 | |
| Edap Technomed INC | $540.00 | 2024 | |
| Karl Storz Endoscopy-America | $467.69 | 2019 | |
| Urogen Pharma, INC. | $354.67 | 2022-2025 | Jelmyto |
| Calyxo, INC. | $346.98 | 2023-2025 | Cvac Aspiration System |
| Olympus America INC. | $141.94 | 2021 | |
| Ethicon US, LLC | $92.85 | 2023 | Enseal X1 |
| Pfizer INC. | $37.63 | 2019-2020 | |
| Tolmar, INC. | $32.73 | 2024 | |
| Civco Medical Instruments | $18.23 | 2025 | |
| Biotissue Holdings INC. | $16.21 | 2020 | |
| Janssen Biotech, INC. | $14.11 | 2022 | |
| Astellas Pharma US INC | $14.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Degen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.